Children’s Cancer Institute shared on LinkedIn:
“Genomic testing can uncover important information about a child’s cancer and genetic makeup.
But understanding what that information means, and what happens next, can be complex.
That’s where genetic counsellors play an important role.
Following Genetic Counsellor Awareness Day, we’re recognising Meg Bourne, Samantha Sandelowsky, Michaela Cormack and Dani Kirby, four of the genetic counsellors supporting the Zero Childhood Cancer Program (ZERO) across Australia.
Working alongside clinicians and researchers, genetic counsellors help connect rapidly evolving genomic science with compassionate, practical care.
They support families through genetic testing, help explain complex results and what they may mean for a child and their relatives, and help families navigate uncertainty and make informed decisions.
Their work can also include coordinating further testing, connecting families with clinical genetics services and supporting appropriate follow-up care.
This can include helping families understand inherited cancer risk, facilitating clinical confirmation of research findings, and supporting referrals for other family members when appropriate.
Genetic counsellors also work closely with oncologists, researchers and other healthcare professionals to help integrate genomics into clinical care and research.
As Michaela explains:
‘We act as a bridge between rapidly evolving genomic science, the healthcare system, and the people whose lives it impacts.’
Importantly, this work isn’t only about interpreting science. It’s also about supporting families through conversations that can be complex and emotionally challenging.
For Samantha, that means ensuring ‘families feel supported, informed and heard, with their individual needs, values and priorities remaining at the centre of every conversation and decision.’
We’re proud to work alongside genetic counsellors across ZERO and grateful for the expertise, communication, compassion and advocacy they bring to children and families facing cancer.”
Other articles about genomic testing on OncoDaily.